Advanced Search

 

Study ID Status Title Patient Level Data
115261 Completed An Open Label, Randomized, Cross-Over Study to Investigate the Single Dose Bioequivalence of Lamotrigine Dispersible/Chewable Tablets (5mg) Compared to Lamotrigine Compressed/Standard Tablets (25mg) in Chinese Healthy Male Subjects
115264 Completed A Pooled-Analysis of Validation Studies of the Chronic Obstructive Pulmonary Disease Assessment Test (CAT) Translated into Local Languages for Asian Patients Study Listed on ClinicalStudyDataRequest.com
115268 Completed Effects of SB-649868 and Alprazolam on the Neuroendocrine and Sympathetic Responses to Insulin-Induced Hypoglycaemia in Healthy Male Subjects
115270 Completed Assessment of physician compliance to recommended liver function test monitoring for Tykerb patients
115283 Completed A randomised, double-blind, placebo-controlled (with rescue medication), multi-centre study to evaluate the efficacy and safety of inhaled fluticasone furoate in the treatment of persistent asthma in adults and adolescents not currently receiving inhaled corticosteroids Study Listed on ClinicalStudyDataRequest.com
115285 Completed A randomised, double-blind, double-dummy, placebo controlled multi-centre study to evaluate the efficacy and safety of fluticasone furoate inhalation powder and fluticasone propionate inhalation powder in the treatment of asthma in adults and adolescents not currently treated with inhaled corticosteroids Study Listed on ClinicalStudyDataRequest.com
115287 Completed Study STF115287, a Clinical Confirmation Study of GSK2585823 (Clindamycin 1%-Benzoyl Peroxide 3% Gel) in the Treatment of Acne Vulgaris in Japanese Subjects. - A multicenter, randomized, single-blind, active-controlled, parallel-group study -
115288 Completed Study STF115288, a Clinical Confirmation Study of GI148512 (Benzoyl Peroxide 3% Gel) in the Treatment of Acne Vulgaris in Japanese Subjects.- A multicenter, randomized, double-blinded, vehicle-controlled, parallel-group study -
115306 Active, Not Recruiting A Phase III, randomized, double-blinded study comparing the combination of the BRAF inhibitor, dabrafenib and the MEK inhibitor, trametinib to dabrafenib and placebo as first-line therapy in subjects with unresectable (Stage IIIC) or metastatic (Stage IV) BRAF V600E/K mutation-positive cutaneous melanoma
115312 Terminated A post-marketing surveillance study of AvamysTM (Fluticasone furoate) in the treatment of Filipino patients with Allergic Rhinitis (AR)
115317 Completed Study ATG115317, a comparison of atorvastatin and glimepiride fixed dose combination and atorvastatin and glimepiride loose combination in the treatment of patients with Type 2 diabetes mellitus Study Listed on ClinicalStudyDataRequest.com
115321 Completed A randomized, double blind, placebo controlled, incomplete block, crossover, dose ranging study to evaluate the dose response of GSK573719 administered once or twice daily over 7 days in patients with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
115324 Completed Special Drug Use Investigation for LAMICTAL Bipolar
115325 Completed A Randomized, Open-Label, Crossover Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ Administered Concurrently in Healthy Adult Subjects
115332 Completed A Single-arm, Open Label Study Evaluating the Impact on Lifestyle of a New Thermo Stable Formulation of FLOLAN® in Subjects with Pulmonary Arterial Hypertension (PAH). (FLOLAN® is a registered trademark of the GlaxoSmithKline group of companies.)
115345 Completed An efficacy study of GSK Biologicals’ quadrivalent influenza vaccine GSK2321138A (FLU D-QIV) when administered in children
115354 Completed PGx411:Evaluation of the Genetic Contribution (efficacy) to the Steroid Response in studies FFA109684, FFA109685 and FFA109687
115354_1 Completed PGx411:Evaluation of the Genetic Contribution (efficacy) to the Steroid Response in studies FFA109684, FFA109685 and FFA109687
115356 Completed To evaluate incidence of acute otitis media in children aged less than 6 years in five East European countries
115358 Completed A 6-month safety and benefit study of inhaled fluticasone propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma Study Listed on ClinicalStudyDataRequest.com
115359 Completed SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma Study Listed on ClinicalStudyDataRequest.com
115360 Completed A Single and Repeat Dose pharmacokinetics/ pharmacodynamics (PK/PD) Study to Characterise theBiomarker Response in Healthy Subjects Treated with the AntiinflammatoryMacrolide Azithromycin
115361 Completed A 52-week, Multi-centre, Open-label Study to Evaluate the Safety and Tolerability of GSK573719 125 mcg once-daily via novel Dry Powder Inhaler (nDPI) in Japanese Subjects with Chronic Obstructive Pulmonary Disease. Study Listed on ClinicalStudyDataRequest.com
115362 Completed A 52-week, Multi-centre, Open-label Study to Evaluate the Safety and Tolerability of GSK573719 125 mcg once-daily in combination with GW642444 25 mcg once-daily via novel Dry Powder Inhaler (nDPI) in Japanese Subjects with Chronic Obstructive Pulmonary Disease. Study Listed on ClinicalStudyDataRequest.com
115373 Completed Safety and immunogenicity study of GSK Biologicals’ pneumococcal vaccine 2830930A when administered as a single dose in healthy toddlers aged 12-23 months

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.